← FDA Drug Approvals (Drugs@FDA)

PANIXINE DISPERDOSE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RANBAXY LABS LTD · Approved 2003-09-11

Drug application

FDA Application #

ANDA065100

Application type

Abbreviated New Drug Application (Generic)

Brand name

PANIXINE DISPERDOSE

Generic name

Cephalexin

Active ingredients

CEPHALEXIN

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

Discontinued

Sponsor

RANBAXY LABS LTD

First approval

2003-09-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown